CMS proposes approval of additional payment for Sequana Medical’s alfapump system in hospital inpatient cases: Ghent, Belgium Tuesday, April 15, 2025, 17:00 Hrs [IST] Sequana Me ...

CMS Proposes Approval of Additional Payment for Sequana Medical's alfapump® system in Hospital Inpatient Cases New Technology Add-on Payment (NTAP) Included in Proposed Fiscal Year 2026 Rule, expected ...

Sequana Medical announced today that CMS recommended that its Alfapump system become eligible for a new incremental payment.

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

BACKGROUND Ascites is a common clinical sign noted in 3% to 4% of hospitalized medical patients. Nearly 94% of patients with ascites have non-malignant etiologies, with the most common being chronic ...

Discover how Akero Therapeutics' EFX outshines competitors in MASH treatment, with groundbreaking results and strong ...

As it progresses, you may experience loss of appetite, fluid retention (ascites), and issues like rectal bleeding. With liver failure, the liver cannot perform essential functions such as filtering ...

The following is a summary of “Calibration and performance of a Raman-based device for non-invasive glucose monitoring in type 2 diabetes,” published in the March 2025 issue of Scientific reports by ...

Medically reviewed by Jay N. Yepuri, MD Metabolic dysfunction-associated fatty liver disease (MAFLD) occurs when excess fat builds up in the liver. MAFLD can progress to metabolic ...

CELSUS noted more than nine hundred years ago that "fluid often collects within the abdomen so that if it be shaken by any movement of the body the fluctuations of the fluid can be seen.

Peritoneal carcinomatosis is a rare form of cancer affecting the peritoneum, the thin membrane surrounding your abdominal organs. Finding out that you or a loved one has it can be tough, and ...